Axogen (AXGN) Cash from Investing Activities (2010 - 2026)

Axogen's (AXGN) quarterly Cash from Investing Activities came in at -$16.0 million in Q1 2026, down 1292.23% year-on-year from $1.3 million in Q1 2025, and down 494.95% quarter-over-quarter from $4.0 million in Q4 2025.

Axogen (AXGN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Axogen's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$16.0 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 1292.23% year-over-year to -$16.0 million in Q1 2026; TTM through Mar 2026 was -$22.6 million, a 296.36% decrease from a year earlier, with the FY2025 full-year figure at -$5.3 million, up 48.36% from the prior year.
  • Cash from Investing Activities slipped to -$16.0 million in Q1 2026 per AXGN's latest filing, from $4.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $14.3 million in Q2 2023 and bottomed at -$16.0 million in Q1 2026.
  • The 5-year median for Cash from Investing Activities is -$813000.0 (2024), against an average of -$913235.3.
  • Across the five-year window, Cash from Investing Activities soared 597.17% in 2025 and sank 1292.23% in 2026, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$1.2 million in 2022, then jumped by 77.09% to -$277000.0 in 2023, then tumbled by 193.5% to -$813000.0 in 2024, then surged by 597.17% to $4.0 million in 2025, then sank by 494.95% to -$16.0 million in 2026.
  • Per Business Quant, the three latest AXGN Cash from Investing Activities figures stand at -$16.0 million (Q1 2026), $4.0 million (Q4 2025), and -$3.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -20.32 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -185.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -92.80 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -298.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -2.50 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -475.32 Mn
10 Axogen 2.12 Bn 2.02 Bn 46.19 Mn -15.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.96 Mn
Mar 31, 2026 -15.96 Mn
Dec 31, 2025 4.04 Mn
Dec 31, 2025 4.04 Mn
Sep 30, 2025 -3.75 Mn
Sep 30, 2025 -3.75 Mn
Jun 30, 2025 -6.95 Mn
Jun 30, 2025 -6.95 Mn
Mar 31, 2025 1.34 Mn
Mar 31, 2025 1.34 Mn
Dec 31, 2024 -813,000.00
Dec 31, 2024 -813,000.00
Sep 30, 2024 -5.00 Mn
Sep 30, 2024 -5.00 Mn
Jun 30, 2024 -1.23 Mn
Jun 30, 2024 -1.23 Mn
Mar 31, 2024 -3.25 Mn
Mar 31, 2024 -3.25 Mn
Dec 31, 2023 -277,000.00
Dec 31, 2023 -277,000.00